Âµg/L

More documents

Recommendations

Info

Rivaroxaban resultat:Antitrombin Coamatic LR (Chromogenix) Xa Berichrom ATIII (Siemens) IIa Stachrom ATIII (Stago) IIa Ref: Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays. J Thromb Haemost. 2011 Jan;9(1):133-9
Rivaroxaban resultat: APC resistens Normal phenotype Normal phenotype Heterozygote phenotype Heterozygote phenotype Coatest APC Resistance V (Chromogenix) APTT- based assay Pefakit APC Resistance FVL (Pentapharm) Prothrombinase – based assay Ref: Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays. J Thromb Haemost. 2011 Jan;9(1):133-9
Page 1 and 2: Nya antikoagulantia - hur påverkas
Page 3 and 4: Koagulationskaskaden - in vivo väg
Page 5 and 6: Spikade plasmaprover Utfördes på
Page 7 and 8: Rivaroxaban: APTT Type of APTT CT 2
Page 9 and 10: Rivaroxaban: PK(INR) Type of PTassa
Page 11 and 12: Dabigatran: APTT Type of APTT CT 2
Page 13 and 14: Dabigatran: PK(INR) Type of PT ”T
Page 15 and 16: a) Fibriprest (Stago) Dabigatran
Page 17 and 18: c) Fib C (IL) Fib C (Instrumentati
Page 19: Slutsats APTT Rivaroxaban och d
Page 23 and 24: Rivaroxaban results: Protein C Prot
Page 25 and 26: Dabigatran resultat: APC resistens
Page 27 and 28: Dabigatran results: Protein C 4,00
Page 29 and 30: Slutsats Protein S (clot ) Rivarox
Page 31: Tack för er uppmärksamhet!

Âµg/L

Create successful ePaper yourself

Delete template?

Save as template?